Effect of Danhong injection on serum high sensitivity C-reactive protein in patients with acute coronary syndrome
Jiang Yabi
Abstract
Jiang Yabi
Abstract
Objective To observe the influence of Danhong injection on serum high sensitivity C-reactive protein (hs-CRP) in patients with acute coronary syndrome (ACS).Methods Eight-six cases with ACS were divided randomly into therapy group(n=43) and control group(n=43),both groups received conventional treatment,moreover,the therapy group was treated with intravenously Danhong injection for two weeks.The levels of serum hs-CRP in both groups were detected before and after treatment.Results There were not statistical difference in the level of serum hs-CRP between both groups before treatment (P0.05).After treatment,the level of hs-CRP in both groups dropped obviously(two P0.01),but it were lower of therapy group than that of control group(P0.01).Conclusion Danhong injection can control plaque inflammation by decreasing serum hs-CRP of ACS patients.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the influence of Danhong injection on serum high sensitivity C-reactive protein (hs-CRP) in patients with acute coronary syndrome (ACS).Methods Eight-six cases with ACS were divided randomly into therapy group(n=43) and control group(n=43),both groups received conventional treatment,moreover,the therapy group was treated with intravenously Danhong injection for two weeks.The levels of serum hs-CRP in both groups were detected before and after treatment.Results There were not statistical difference in the level of serum hs-CRP between both groups before treatment (P0.05).After treatment,the level of hs-CRP in both groups dropped obviously(two P0.01),but it were lower of therapy group than that of control group(P0.01).Conclusion Danhong injection can control plaque inflammation by decreasing serum hs-CRP of ACS patients.
Key concepts: Medicine, Acute coronary syndrome, C-reactive protein, Internal medicine, Gastroenterology, Inflammation, Myocardial infarction